The Cardiovascular System and Sites for Drug Effects
Amy Howard
This session describes the basic anatomy of the cardiovascular system, as well as drugs that primarily affect it and their sites of action.
Opioids with Weak and Partial Agonist Activity and Opioid Antagonists
Kimberley Hoyland
This session describes the pharmacology and uses of weak opioids such as codeine, as well as partial agonist and mixed agonist/antagonist drugs, and lists the problems associated with their use. It also examines the pharmacology and use of μ receptor antagonists.
Introduction to Pharmacokinetics and Modelling
Sue Hill
This session will introduce pharmacokinetics and modelling. The simple one-compartment model will be described and reasons presented as to why such a model rarely describes drug behaviour.
Mechanism of General Anaesthetic Action
Shelley Barnes, Jeffrey Handel, and Madeleine Storey
This session describes the ways in which general anaesthetic agents are hypothesized to exert their effects at the cellular and molecular level.
Strengthening the One Health Approach to AMR Surveillance
Dr Cheikh Fall
In this Antimicrobial (AMR) Community of Practice (CoP) webinar, we discuss the One Health approach to addressing antimicrobial resistance (AMR). This approach provides significant opportunities to explore broadly-existing microbial relationships between humans and animals. In this session, from the genomic point of view, the In....
Strengthening the Quality of AMR Diagnostics
Professor Olga Perovic
In this Antimicrobial (AMR) Community of Practice (CoP) webinar, we discuss our approach to establishing regional external quality assessment (EQA) providers and the achievements and lessons learnt from the implementation of a regional EQA programme for AMR. This AMR CoP and webinar are supported by the Fleming Fund’s EQA Grant....
Introducing the HIV Laboratory Waste Cost Assessment Framework
Ritu Shrivastava
LabCoP’s February ECHO session introduced the HIV Laboratory Waste Cost Assessment Framework (WCAF), an MS Excel-based tool co-developed by the US CDC and Roche Diagnostics, under a public-private partnership to support accurate quantification of solid and liquid wastes generated in PEPFAR-supported countries, to allow easy comm....
Genomic Surveillance of SARS-CoV-2 in Africa
Dr Sofonias K Tessema
On 10 Feb 2022, ASLM held this ECHO session to cover genomic surveillance for SARS-COV-2 in Africa by Africa CDC’s Africa Pathogen Genomics Initiative (Africa PGI). This initiative, a continental program launched in October 2020, aims to establish pathogen genomics and bioinformatics capacity in support of disease surveillance.....
The Global Access Diagnostics COVID-19 Antigen Rapid Diagnostic Test, COVIOS
Mark Radford and Dr Emily Adams
On 2 September 2021, this COVID-19 ECHO session was convened to share details on the COVIOS antigen rapid diagnostic test (Ag RDT) technology, status of regulatory approval, requirements/consumables to operate the test, and how Ag RDTs can be deployed to support testing programmes for COVID-19 epidemic control. COVIOS, developed....
Implementation of the Lateral-Flow Urine Lipoarbinomannan Assay
Martina Casenghi, Nathan Ford and Morten Ruhwald
On 30 June 2021 this Extended ECHO session was convened to discuss the implementation of the Lateral-Flow Urine Lipoarabinomannan (LF-LAM) assay for the detection of active tuberculosis (TB) in people living with HIV. The session provided an overview of current World Health Organisation (WHO) recommendations, practical consider....
LabCoP M&E Sub-CoP ECHO Session June 2021
Hiwot Haile-Selassie and Faith Ngari
In June the ASLM LabCoP monitoring and evaluation (M&E) Sub-CoP held an ECHO session on viral load (VL) testing data quality assessment. The presentation provided an overview of the 2020 WHO-UNAIDS-PEPFAR-Global Fund module for assessing and strengthening the quality of VL testing data within HIV programmes and patient monitorin....
LabCoP M&E Sub-CoP ECHO Session Early April 2021
Nadia Solehdin, and Jonathan Ntale
On 1 April 2021, ASLM`s LabCoP M&E Sub-CoP, in collaboration with U.S. Centers for Disease Control and Prevention (CDC), Division of Global HIV and Tuberculosis (DGHT) convened a session focusing on indicators for scale-up of viral load (VL) testing and program outcomes. Presentations were made by Nadia Solehdin, an epidemiologi....
Respectful Maternity Care
Dr Sarah Little
This module provides training and mentorship instruction for conducting Respectful maternity care.
Antepartum Haemorrhage (APH)
Dr Sarah Little
This module provides training and mentorship instruction for management of Antepartum hemorrhage.
Breech Delivery
Dr Sarah Little
This module provides training and mentorship instruction on how to conduct a vaginal breech delivery.
Shoulder Dystocia
Dr Sarah Little
This module provides training and mentorship instruction for the management of Shoulder dystocia
Fluid Balance Homeostasis
John Findlay, and Ridzuan Farouk
This session aims to provide a practical understanding of the physiology of fluid balance and renal failure, to aid trainees in their management of the surgical patient.
Provider Training for Long-Acting Injectable Cabotegravir (CAB-LA) as HIV Pre-Exposure Prophylaxis (PrEP)
Jhpiego, an affiliate of Johns Hopkins University
The training materials included in this toolkit will help clinicians learn about and provide CAB-LA as an HIV prevention option for their clients. Build your knowledge of CAB-LA for HIV PrEP by completing the CAB-LA online lessons. Work your way through a series of eLearning lessons, which will build your knowledge of CAB-....
Lesson 1: The Basics of Cabotegravir (CAB) for HIV Prevention
Jhpiego, an affiliate of Johns Hopkins University
Explore cabotegravir (CAB) basic administration and the evidence from research studies that CAB reduces HIV infections.
Lesson 2: Relative Advantages and Disadvantages of Long-acting Cabotegravir (CAB-LA)
Jhpiego, an affiliate of Johns Hopkins University
In this lesson, we will explore attributes of long-acting injectable cabotegravir (CAB-LA) that may be viewed as advantages or disadvantages in comparison to other forms of pre-exposure prophylaxis (PrEP).
Social development in adolescence
Deborah Christie
This session will review the reciprocal impact of changes in social development in adolescence. The session will also consider what impact these developmental changes have on self-management of long-term illness during adolescence.
Healthy Development in Adolescence
Russell Viner
This session introduces normal development in adolescents in key biological, psychological and social domains, and the impact of these upon their health and illness. The importance of psychosocial development for long-term condition self-management and concordance is also discussed.
Concepts of Puberty
Russell Viner
This session introduces key concepts relating to puberty such as: potential issues, biological changes, Tanner stages and timings. The onset of the reproductive function and the pubertal growth spurt are also discussed.
Diagnosing Chlamydia
Caroline Carder
This session explains how to diagnose chlamydia. It describes what samples to take and their storage and transport. It explains diagnostic tests, how to perform them, their sensitivity and specificity and their potential advantages or disadvantages. The timescales between exposure and tests becoming positive and between treatmen....
Public Health Aspects of Age Related Macular Degeneration (ARMD)
Andy Cassels-Brown and Aditi Das
This session will provide an overview of ARMD from a public health perspective.